Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 PLEXXIKON INC., Case No. 17-cv-04405-HSG Plaintiff, ORDER GRANTING IN PART AND

DENYING IN PART DEFENDANT’S

v. MOTION TO STRIKE AND

DEFENDANT’S MOTION IN LIMINE

NOVARTIS PHARMACEUTICALS NO.

CORPORATION,

Re: Dkt. No. 272, 307 Defendant. 12 Pending before the Court are two motions related to Plaintiff Plexxikon Inc.’s damages expert Dr. Gregory K. Leonard, and his reasonable royalty rate calculations. In its motion in limine (“MIL”), Defendant Novartis Pharmaceuticals Corporation moves to preclude Plaintiff from offering evidence relating to damages for any period before October 2016 or after December 2018, the timeframe that Dr. Leonard considered in his opening expert report and his First Supplemental Report. See Dkt. No. 272. Defendant also moves to strike Dr. Leonard’s Second Supplemental Report, served on October 4, 2019, arguing that it improperly considers damages after…